| 05/05/2026 3:30 PM | Adaptive Biotechnologies (1478320) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/29/2026 6:08 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:29 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 3:30 PM | Adaptive Biotechnologies (1478320) Filer | Form DEF 14A | |
| 04/24/2026 3:31 PM | Adaptive Biotechnologies (1478320) Filer | Form DEFA14A | |
| 04/24/2026 3:32 PM | Adaptive Biotechnologies (1478320) Filer | Form ARS | |
| 04/21/2026 5:07 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 6:36 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 6:44 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/10/2026 5:48 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS HARLAN S (1780851) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/10/2026 5:52 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ADPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Adaptive Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/08/2026 6:48 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 6:51 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS CHAD M (1780649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 3:58 PM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/08/2026 3:58 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/08/2026 3:33 PM | Adaptive Biotechnologies (1478320) Subject LO FRANCIS (1780660) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/06/2026 4:22 PM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/02/2026 6:16 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 5:56 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 6:41 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 2:12 PM | Adaptive Biotechnologies (1478320) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 6:18 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 5:21 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/16/2026 8:00 PM | Adaptive Biotechnologies (1478320) Subject BENZENO SHARON (1780854) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 8:05 PM | Adaptive Biotechnologies (1478320) Subject BOBULSKY SUSAN (1820885) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 7:53 PM | Adaptive Biotechnologies (1478320) Subject PISKEL KYLE (1780662) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 7:40 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 7:46 PM | Adaptive Biotechnologies (1478320) Subject RUBINSTEIN JULIE (1780664) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 7:33 PM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/13/2026 8:36 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 7:52 PM | Adaptive Biotechnologies (1478320) Issuer PISKEL KYLE (1780662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 7:55 PM | Adaptive Biotechnologies (1478320) Issuer BENZENO SHARON (1780854) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 7:59 PM | Adaptive Biotechnologies (1478320) Issuer BOBULSKY SUSAN (1820885) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 8:02 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 8:05 PM | Adaptive Biotechnologies (1478320) Issuer GRIFFIN MICHELLE RENEE (1229765) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 7:45 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS CHAD M (1780649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 7:49 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS HARLAN S (1780851) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/10/2026 7:04 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/10/2026 6:53 PM | Adaptive Biotechnologies (1478320) Subject LO FRANCIS (1780660) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/09/2026 7:29 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:59 PM | Adaptive Biotechnologies (1478320) Issuer NEUPERT PETER M (1237566) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 03/06/2026 6:49 PM | Adaptive Biotechnologies (1478320) Issuer HERSHBERG ROBERT (1274139) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:28 PM | Adaptive Biotechnologies (1478320) Issuer BENZENO SHARON (1780854) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:31 PM | Adaptive Biotechnologies (1478320) Issuer BOBULSKY SUSAN (1820885) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:35 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:17 PM | Adaptive Biotechnologies (1478320) Issuer PISKEL KYLE (1780662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:21 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS HARLAN S (1780851) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:25 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:05 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS CHAD M (1780649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:08 PM | Adaptive Biotechnologies (1478320) Issuer GRIFFIN MICHELLE RENEE (1229765) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 6:10 PM | Adaptive Biotechnologies (1478320) Issuer OWEN KATEY EINTERZ (1852578) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 7:05 PM | Adaptive Biotechnologies (1478320) Issuer GRIFFIN MICHELLE RENEE (1229765) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 6:42 PM | Adaptive Biotechnologies (1478320) Issuer RUBINSTEIN JULIE (1780664) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 6:58 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS HARLAN S (1780851) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 6:51 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS CHAD M (1780649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 4:24 PM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 4:24 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/26/2026 3:31 PM | Adaptive Biotechnologies (1478320) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/06/2026 6:30 PM | Adaptive Biotechnologies (1478320) Issuer PISKEL KYLE (1780662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 3:15 PM | Adaptive Biotechnologies (1478320) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/04/2026 6:37 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS CHAD M (1780649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 6:48 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS HARLAN S (1780851) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 4:09 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 4:24 PM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 4:26 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/14/2026 6:42 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 6:17 PM | Adaptive Biotechnologies (1478320) Issuer PISKEL KYLE (1780662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 3:26 PM | Adaptive Biotechnologies (1478320) Subject PISKEL KYLE (1780662) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 3:27 PM | Adaptive Biotechnologies (1478320) Subject LO FRANCIS (1780660) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 7:15 AM | Adaptive Biotechnologies (1478320) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 7:17 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS HARLAN S (1780851) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/07/2026 7:52 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4/A | |
| 01/07/2026 7:30 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS CHAD M (1780649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 6:52 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:57 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/05/2026 5:22 PM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/30/2025 7:00 AM | Adaptive Biotechnologies (1478320) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/29/2025 5:27 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 6:06 PM | Adaptive Biotechnologies (1478320) Issuer LO FRANCIS (1780660) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 6:11 PM | Adaptive Biotechnologies (1478320) Issuer HERSHBERG ROBERT (1274139) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/08/2025 7:00 PM | Adaptive Biotechnologies (1478320) Issuer BENZENO SHARON (1780854) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/05/2025 5:30 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS HARLAN S (1780851) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/04/2025 4:15 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/04/2025 3:38 PM | Adaptive Biotechnologies (1478320) Subject BENZENO SHARON (1780854) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/03/2025 4:58 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/02/2025 5:45 PM | Adaptive Biotechnologies (1478320) Issuer PISKEL KYLE (1780662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 6:27 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS CHAD M (1780649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 5:03 PM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/28/2025 12:18 PM | Adaptive Biotechnologies (1478320) Subject PISKEL KYLE (1780662) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/26/2025 4:30 PM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/24/2025 8:39 PM | Adaptive Biotechnologies (1478320) Issuer BENZENO SHARON (1780854) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 11/24/2025 3:58 PM | Adaptive Biotechnologies (1478320) Subject BENZENO SHARON (1780854) Reporting | Form 144/A | |
| 11/21/2025 3:45 PM | Adaptive Biotechnologies (1478320) Subject BENZENO SHARON (1780854) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/20/2025 3:25 PM | Adaptive Biotechnologies (1478320) Subject BENZENO SHARON (1780854) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/19/2025 3:22 PM | Adaptive Biotechnologies (1478320) Subject BENZENO SHARON (1780854) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 6:14 PM | Adaptive Biotechnologies (1478320) Issuer PISKEL KYLE (1780662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2025 6:19 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS CHAD M (1780649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2025 6:30 PM | Adaptive Biotechnologies (1478320) Issuer ROBINS HARLAN S (1780851) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2025 7:09 AM | Adaptive Biotechnologies (1478320) Subject ROBINS CHAD M (1780649) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2025 5:48 PM | Adaptive Biotechnologies (1478320) Subject ROBINS HARLAN S (1780851) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |